• EGCG Nanoparticles Enhance FLASH-RT Efficacy via DNA Damage

  2026-04-24

  This study introduces functionalized self-assembled EGCG nanoparticles (BENPs) as radiosensitizers that significantly boost the antitumor effects of ultra-high dose rate radiotherapy (FLASH-RT). The findings highlight enhanced DNA damage, immune activation, and tumor suppression, offering translational potential for optimizing cancer radiotherapy strategies.

• Digoxin as a Na+/K+ ATPase Pump Inhibitor: Applied Protocols

  2026-04-24

  Digoxin empowers research teams with dual functionality: precise cardiac contractility modulation and targeted inhibition of chikungunya virus infection in vitro. This article unlocks stepwise workflows, optimization strategies, and troubleshooting tips for leveraging high-purity Digoxin from APExBIO in both cardiovascular and antiviral research models.

• MEK1/2-c-Myc-Max Axis Prevents Polycomb Repression of TERT i

  2026-04-23

  This study reveals that MEK1/2 kinases and the c-Myc-Max complex cooperatively prevent polycomb-mediated repression of TERT, ensuring telomerase activity in human pluripotent stem cells. The findings clarify a key mechanism underlying telomere maintenance and suggest new experimental avenues for dissecting telomerase regulation.

• Bispecific Antibody Design for Broad Orthopoxvirus Protectio

  2026-04-23

  This study presents a comprehensive characterization of anti-M1R and anti-B6R monoclonal antibodies and demonstrates that bispecific antibody formats can enhance protection against mpox and related orthopoxviruses. The findings have direct implications for therapeutic development and future antibody-based countermeasures.

• RG7388 (MDM2 Antagonist): Precision Tools for p53 Pathway Re

  2026-04-22

  Explore the advanced scientific and experimental rationale for RG7388, a potent MDM2 antagonist, in p53 pathway activation and cancer cell apoptosis induction. This article uniquely integrates the latest biomarker-driven insights with practical assay guidance.

• Trichostatin A: Precision Epigenetic Modulation in Cancer Re

  2026-04-22

  Trichostatin A (TSA) from APExBIO empowers researchers to precisely manipulate cellular epigenetics, driving breakthroughs in both oncology and immunology. This article details optimized protocols, real-world troubleshooting, and how TSA’s unique mechanism extends its application beyond conventional cancer models.

• HyperScribe Co-transcription mRNA Synthesis Kit Plus: Workfl

  2026-04-21

  The HyperScribe Co-transcription mRNA Synthesis Kit Plus (ARCA, T7) streamlines high-yield, ARCA-capped, polyadenylated mRNA production for advanced applications from vaccine development to functional RNA studies. This article details bench-proven workflows, optimization tips, and troubleshooting strategies grounded in translational research and recent breakthroughs in immunotherapy.

• BMS-345541 Hydrochloride: Selective IKK Inhibitor for NF-κB

  2026-04-21

  BMS-345541 hydrochloride is a potent and selective IKK inhibitor used in inflammation research and studies of apoptosis induction in T-ALL. Its high specificity and oral bioavailability make it a benchmark tool for dissecting NF-κB signaling with minimal off-target effects. This article summarizes its mechanism, evidence base, and workflow integration for advanced cancer biology research.

• 5-Methyl-CTP (SKU B7967): Reliable Solutions for mRNA Synthe

  2026-04-20

  This article provides an evidence-based, scenario-driven guide for biomedical researchers and lab technicians using 5-Methyl-CTP (SKU B7967) to address persistent challenges in mRNA synthesis, stability, and translation. Drawing on recent literature and validated protocols, it highlights how this modified nucleotide supports reproducible, high-efficiency workflows essential for mRNA drug development and advanced cell-based assays.

• Influenza Hemagglutinin (HA) Peptide: Precision Tag for Prot

  2026-04-20

  Unlock reproducible, high-fidelity protein purification and detection with the Influenza Hemagglutinin (HA) Peptide from APExBIO. This high-purity, highly soluble epitope tag elevates immunoprecipitation workflows and empowers advanced exosome research. Explore protocol enhancements, troubleshooting, and insights from cutting-edge exosome biogenesis studies.

• Letrozole: Applied Workflows for Non-Steroidal Aromatase Inh

  2026-04-19

  Letrozole is a potent non-steroidal aromatase inhibitor that empowers researchers to model hormone-dependent cancers with precision. This article delivers actionable, data-driven workflows and troubleshooting insights, directly translating mechanistic knowledge and recent literature into practical laboratory protocols.

• EZ Cap™ Firefly Luciferase mRNA (5-moUTP): Benchmarks & Mech

  2026-04-18

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) is a 5-moUTP modified mRNA providing robust, low-immunogenic bioluminescent reporter gene expression. Its Cap 1 structure and optimized poly(A) tail increase translational efficiency and stability, establishing it as a reproducible standard for mRNA delivery and translation efficiency assays.

• Transdermal PTEN mRNA-HA-LNPs: Advancing Skin Cancer Immunot

  2026-04-17

  This study introduces a hyaluronated lipid nanoparticle (HA-LNP) system for the non-invasive, transdermal delivery of PTEN tumor suppressor gene mRNA in melanoma models. By leveraging HA-mediated targeting and efficient mRNA encapsulation, the platform enhances tumor penetration, restores PTEN expression, and improves antitumor immune responses, suggesting a promising approach for localized mRNA-based immunotherapy.

• Ginsenoside Rg1 for Neuroimmune Modulation: Lab-Ready Insigh

  2026-04-16

  This technical review bridges real-world laboratory scenarios with best practices for using Ginsenoside Rg1 (SKU N1613) in cell viability, neuroprotection, and apoptosis assays. Drawing on recent evidence, it demonstrates how APExBIO's Ginsenoside Rg1 enables reproducible, data-rich workflows for neuroimmune modulation and anti-inflammatory research.

• KPT-330 (Selinexor), selective CRM1 inhibitor: Best Practice

  2026-04-15

  This article guides biomedical researchers and lab technicians through real-world challenges in apoptosis, cell cycle, and cytotoxicity assays using KPT-330 (Selinexor), selective CRM1 inhibitor (SKU B1464). Evidence-backed scenarios illustrate protocol optimization, data interpretation, and vendor selection—highlighting SKU B1464’s reproducibility and application breadth.

14803 records 1/987 page Next 12345 下5页 Last page